Inventor
BERNARD MLECNIK
Inventor
FR
Overview
Patents· 2 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms50%
PatentTitleYear
12,291,752Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes202511,242,564Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ASSIST PUBLIQUE HOPITAUX PARIS APHP (2)· patent assignee history
2022–2025Patents assigned to INST NAT SANTE RECH MED (2)· patent assignee history
2022Patents assigned to UNIV PARIS (1)· patent assignee history
2022–2025Based in FR· patent location history
2025Patents assigned to UNIV DE PARIS DESCARTES (1)· patent assignee history
2025Patents assigned to UNIV PARIS CITE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASSIST PUBLIQUE HOPITAUX PARIS APHP | 2 | 2022–2025 |
| INST NAT SANTE RECH MED | 2 | 2022–2025 |
| UNIV DE PARIS DESCARTES | 1 | 2025 |
| UNIV PARIS | 1 | 2022 |
| UNIV PARIS CITE | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 2 | 2022–2025 |